Taxation
Knowcraft Analytics is your trusted partner in navigating the complex landscape of taxation in the US and Canada. Our dedicated team of tax professionals provides expert solutions tailored for US and Canada businesses with its rich experience in the US and Canada tax practices and has executed over 2,500 tax returns delivering the highest quality services.
We collaborate with numerous small, medium, and large CPA firms across the US and Canada to provide scalable & personalized taxation services. Our best practices assist clients in taxation planning and consulting to advise optimal refunds and reduce tax liabilities. We have a team of seasoned CPAs, EAs and CAs specializing in the financial statement analyses and tax implications of various accounts.
Individual Tax
Read More
Business Tax
Read More
Estate/trust Tax
Read More
Gift Tax
Read More
Non-profit Tax
Read More
Never Filed, Need To File or Amend Your Returns
Read More
Multi-state Tax
Read More
Engagement Administrative Support Services
Read More
Indirect Tax Compliance
Read More
Experts Behind the Wheel
Anshuman Thakur
President
Hitesh Rajput
Associate Vice President
Why Choose Knowcraft for Taxation?
Experienced Professionals with Consulting Mindset
Qualified Team & Streamlined Tax Processes
Executed Over 2,500 Tax Returns
Scalable Outsourcing Model
Case Studies
Contingent Consideration Valuation
THE CLIENT AND THE ASK: A pharmaceutical company (the “Acquirer”) acquired a biotechnology company (the “Company”) in exchange for an upfront payment and certain payments contingent upon successful achievement of future regulatory and sales milestones for certain...
Forecasting and Valuation
THE COMPANY AND THE ASK: The Company is a technology company with a business proposition to provide diagnostic services to rural India and reduce the turnaround time of getting the report from 24 hours to 1 hour. The Company was operating using multiple business...
IRC – 409A Valuation of Common Stock
THE COMPANY: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...